行情

ATHE

ATHE

Alterity Therapeutics Ltd
NASDAQ

实时行情|Nasdaq Last Sale

0.6250
+0.0050
+0.81%
交易中 12:07 04/02 EDT
开盘
0.6300
昨收
0.6200
最高
0.6900
最低
0.5174
成交量
1.10万
成交额
--
52周最高
2.550
52周最低
0.2800
市值
908.97万
市盈率(TTM)
-0.8941
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ATHE价格均价为4.000,最高价位4.000,最低价为4.000。

EPS

ATHE 新闻

更多
  • 58同城收到鸥翎投资收购要约 股价涨近14%
  • 新浪美股 · 59分钟前
  • 58同城获得一份不具约束力收购要约 股价临时停牌
  • 新浪科技 · 1小时前
  • 普京宣布将俄带薪非工作日实行期限延至4月30日
  • 中国新闻网 · 1小时前
  • 抗议和罢工起作用了!亚马逊要为员工量体温发口罩
  • 新浪科技 · 1小时前

所属板块

生物技术和医学研究
+2.03%
制药与医学研究
+1.53%

热门股票

代码
价格
涨跌幅

ATHE 简况

Alterity Therapeutics Limited, formerly Prana Biotechnology Limited, is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological disorders. The Company's lead product candidates are PBT2 and PBT434. The Company's lead drug candidate PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. The Company also has advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing. Its other applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease (the human variant of Mad Cow disease), and a range of orphan neurodegenerative disorders.
展开

微牛提供Alterity Therapeutics Ltd (ADR)(NASDAQ-ATHE)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ATHE股票新闻,以帮助您做出投资决策。